Trulicity Trulicity (dulaglutide) helps to improve blood sugar control in adults and children ages 10 years and older with type 2 diabetes and is also prescribed to prevent heart attacks and strokes in adults with cardiovascular disease or risk factors for cardiovascular disease
Often the first-line option for patients new to GLP-1 therapy
Generalized tonic-clonic (GTC) is the most common seizure type, followed by tonic, clonic, myoclonic, seizures with impaired awareness (SIA), and spasms
A fasting glucose test, HbA1c, or fasting insulin level can help assess your metabolic health, helping you and your provider get to the root of the problem
The following sources provide product and safety information for semaglutide tablets: Official Rybelsus patient information DailyMed prescribing information Novo Nordisk manufacturer information Rybelsus can be a useful oral GLP-1 option for adults managing type 2 diabetes, especially when the daily fasting routine is realistic
The slightly higher range with semaglutide likely reflects the more dramatic calorie reduction and the tendency for users to eat less protein overall due to sustained appetite suppression
